Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Gale
  • Ivermectin
  • Oral Parasitic Drug
  • Severe Forms of Scabies
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02841215
Collaborators
Not Provided
Investigators
Principal Investigator: Giao DO-PHAM, MD Assistance Publique - Hôpitaux de Paris